Cookie Consent by Free Privacy Policy Generator

PRCA Medical Abbreviation

Author: Analgesia logo

Last Updated on May 16, 2025 by Analgesia team

Pure Red Cell Aplasia & Anaemia

PRCA is a form of chronic anaemia caused by a near-complete failure of red cell production in the bone marrow. The condition results in low red blood cell counts, often with normal white blood cells and platelets.

In simpler terms: The factory (bone marrow) keeps making soldiers (white blood cells) and medics (platelets), but stops producing transporters (red blood cells), leading to oxygen delivery problems.

Pure red cell aplasia (PRCA)

What it is

A rare blood disorder that causes anemia by reducing the bone marrow’s production of red blood cells

Causes

PRCA can be either congenital (present from birth) or acquired later in life. Acquired PRCA may be linked to:
  • Autoimmune disorders, such as systemic lupus erythematosus (SLE)

  • Viral infections, especially parvovirus B19

  • Thymoma and other solid tumours

  • Lymphoproliferative diseases, like chronic lymphocytic leukaemia

  • Large granular lymphocyte (LGL) leukaemia

  • Medications or exposure to toxins

  • Major or bidirectional ABO-incompatible stem cell transplants

Symptoms

People with PRCA often experience symptoms related to severe anaemia, including:

  • Fatigue

  • Shortness of breath

  • Paleness

  • Dizziness or fainting

  • Rapid heartbeat

Lab findings include:

  • Persistent anaemia

  • Reticulocytopenia (low immature red cells)

  • Bone marrow that lacks erythroid precursors (cells that become red blood cells)

Treatment

Treatment depends on the underlying cause:

  • Immunosuppressive therapy (e.g. corticosteroids or cyclosporine) is often the first-line

  • Antiviral therapy if PRCA is caused by parvovirus B19

  • Tumour resection if a thymoma is present

  • Immunoglobulin replacement therapy for immunodeficiency-related cases

The bottom line? PRCA is treatable, but requires a targeted approach based on what’s driving the condition.

PRCA can be a complication of major or bidirectional ABO-incompatible allogeneic hematopoietic stem cell transplants (allo-HSCT). It can also be associated with collagen vascular/autoimmune disorders such as systemic lupus erythematosus, lymphoproliferative disorders such as chronic lymphocytic leukaemia or large granular lymphocyte leukaemia, infections, particularly B19 parvovirus, thymoma and other solid tumours. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to Top